Education level as a predictor of survival in patients with multiple myelomaLimei Xu, Juan Li, Xiuju Wang et al.|BMC Cancer|2020Cited by 28
Results of a registrational Phase 2 study of lisaftoclax monotherapy for treatment of patients (pts) with Relapsed/Refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who had failed Bruton's tyrosine kinase inhibitors (BTKis)Keshu Zhou, Jianyong Li, Jie Jin et al.|Blood|2025Cited by 0